FDA Inspection
LGM Pharma LLCLGM Pharma LLC – FDA Inspection, Apr 8, 2022
Record Details
This FDA Inspection record concerns LGM Pharma LLC, with an inspection on April 8, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- LGM Pharma LLC
- Inspection Date
- April 8, 2022
- Product Type
- Drugs
View Company Profile
ID · c2ba459e-719c-4b9c-84ed-25f4493fe073
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1166776
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of LGM Pharma LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 12, 2026 | Not classified | Cincinnati District Office | |
| June 28, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 4, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for LGM Pharma LLC
- FDA Inspection 1312800 - 2026-03-12
- FDA Inspection 1242488 - 2024-06-28
- FDA Inspection 1073414 - 2018-12-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.